Dey A, Vaishak K, Deka D, Radhakrishnan A, Paul S, Shanmugam P
Infection. 2023; 51(6):1603-1618.
PMID: 36906872
PMC: 10008189.
DOI: 10.1007/s15010-023-02017-8.
Udoakang A, Djomkam Zune A, Tapela K, Nganyewo N, Olisaka F, Anyigba C
Front Immunol. 2023; 14:1104828.
PMID: 36776887
PMC: 9911459.
DOI: 10.3389/fimmu.2023.1104828.
Pierri F, DeVerna M, Yang K, Axelrod D, Bryden J, Menczer F
J Med Internet Res. 2023; 25:e42227.
PMID: 36735835
PMC: 9970010.
DOI: 10.2196/42227.
Guo L, Yao H, Chen W, Wang X, Ye P, Xu Z
Hortic Res. 2022; 9:uhac223.
PMID: 36479585
PMC: 9720450.
DOI: 10.1093/hr/uhac223.
Kolodny O, Berger M, Feldman M, Ram Y
Open Biol. 2022; 10(7):200138.
PMID: 36416599
PMC: 7574546.
DOI: 10.1098/rsob.200138.
A phylogenetic perspective of antiviral species of the genus (Asteraceae-Anthemideae): A proposal of anti SARS-CoV-2 (COVID-19) candidate taxa.
Hussain A
J Herb Med. 2022; 36:100601.
PMID: 36188629
PMC: 9514968.
DOI: 10.1016/j.hermed.2022.100601.
A computational study of potential therapeutics for COVID-19 invoking conceptual density functional theory.
Saloni , Kumari D, Ranjan P, Chakraborty T
Struct Chem. 2022; 33(6):2195-2204.
PMID: 36097582
PMC: 9452875.
DOI: 10.1007/s11224-022-02048-1.
Detecting drug-drug interactions between therapies for COVID-19 and concomitant medications through the FDA adverse event reporting system.
Jeong E, Nelson S, Su Y, Malin B, Li L, Chen Y
Front Pharmacol. 2022; 13:938552.
PMID: 35935872
PMC: 9353301.
DOI: 10.3389/fphar.2022.938552.
Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.
Marin S, Martin Val A, Peligero M, Rodriguez-Bernuz C, Perez-Ricart A, Vilaro Jaques L
Pharmaceuticals (Basel). 2022; 15(5).
PMID: 35631460
PMC: 9144263.
DOI: 10.3390/ph15050634.
Virtual Coaching Delivered by Pharmacists to Prevent COVID-19 Transmission.
H Abdel-Qader D, Al Meslamani A, Al Mazrouei N, El-Shara A, El Sharu H, Merghani Ali E
Hosp Pharm. 2022; 57(2):300-308.
PMID: 35601726
PMC: 9117773.
DOI: 10.1177/00185787211032354.
Immune-based therapeutic approaches in COVID-19.
Moeinafshar A, Yazdanpanah N, Rezaei N
Biomed Pharmacother. 2022; 151:113107.
PMID: 35594701
PMC: 9108029.
DOI: 10.1016/j.biopha.2022.113107.
Several coumarin derivatives and their Pd(ii) complexes as potential inhibitors of the main protease of SARS-CoV-2, an approach.
Milenkovic D, Dimic D, Avdovic E, Markovic Z
RSC Adv. 2022; 10(58):35099-35108.
PMID: 35515669
PMC: 9056878.
DOI: 10.1039/d0ra07062a.
Rifampicin for COVID-19.
Panayiotakopoulos G, Papadimitriou D
World J Virol. 2022; 11(2):90-97.
PMID: 35433334
PMC: 8966591.
DOI: 10.5501/wjv.v11.i2.90.
Nutrition intervention in the management of novel coronavirus pneumonia patients.
Cai H, Wang Y, Cai Z, Lin Y, Xu Q
Open Life Sci. 2022; 17(1):243-247.
PMID: 35415243
PMC: 8951197.
DOI: 10.1515/biol-2022-0015.
Multiscale Model of Antiviral Timing, Potency, and Heterogeneity Effects on an Epithelial Tissue Patch Infected by SARS-CoV-2.
Ferrari Gianlupi J, Mapder T, Sego T, Sluka J, Quinney S, Craig M
Viruses. 2022; 14(3).
PMID: 35337012
PMC: 8953050.
DOI: 10.3390/v14030605.
In silico Design and Characterization of Multi-epitopes Vaccine for SARS-CoV2 from Its Spike Protein.
Kathwate G
Int J Pept Res Ther. 2022; 28(1):37.
PMID: 35002585
PMC: 8722413.
DOI: 10.1007/s10989-021-10348-z.
Comparative MD Study of Inhibitory Activity of Opaganib and Adamantane-Isothiourea Derivatives toward COVID-19 Main Protease M.
dorovic Jovanovic J, Antonijevic M, El-Emam A, Markovic Z
ChemistrySelect. 2021; 6(33):8603-8610.
PMID: 34909459
PMC: 8662094.
DOI: 10.1002/slct.202101898.
Understanding the clinical utility of favipiravir (T-705) in coronavirus disease of 2019: a review.
Srinivasan K, Rao M
Ther Adv Infect Dis. 2021; 8:20499361211063016.
PMID: 34881025
PMC: 8646822.
DOI: 10.1177/20499361211063016.
Potential inhibitors of SARS-CoV-2 (COVID 19) proteases PL and M/ 3CL: molecular docking and simulation studies of three pertinent medicinal plant natural components.
Verma D, Mitra D, Paul M, Chaudhary P, Kamboj A, Thatoi H
Curr Res Pharmacol Drug Discov. 2021; 2:100038.
PMID: 34870149
PMC: 8178537.
DOI: 10.1016/j.crphar.2021.100038.
Traditional Uses, Nutritional and Pharmacological Potentials of .
Okaiyeto K, Falade A, Oguntibeju O
Plants (Basel). 2021; 10(9).
PMID: 34579425
PMC: 8472598.
DOI: 10.3390/plants10091893.
